TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Sakaguchi, Masakiyo ^a   Murata, Hitoshi ^a   Yamamoto, Ken ichi ^a   Ono, Tomoyuki ^a   Sakaguchi, Yoshihiko ^b   Motoyama, Akira ^c   Hibino, Toshihiko ^c   Kataoka, Ken ^a   Huh, Nam ho ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c SHISEIDO RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN TIRAP; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 1 RECEPTOR; LIGAND; MEMBRANE PROTEIN; PROTEIN KINASE C; PROTEIN KINASE C ZETA; SERINE; TIRAP PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; LIGAND BINDING; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UMBILICAL VEIN ENDOTHELIAL CELL; CELL LINE; CHEMISTRY; COCULTURE; CYTOPLASM; GENETICS; IMMUNOPRECIPITATION; METABOLISM; NORTHERN BLOTTING; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; COCULTURE TECHNIQUES; CYTOPLASM; HUMANS; IMMUNOPRECIPITATION; LIGANDS; MEMBRANE GLYCOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN-1; RNA INTERFERENCE; SERINE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 79960959115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023132     Document Type: Article

References (36)

1. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, et al. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004.
2. Schmidt AM, Hori O, Cao R, Yan SD, Brett J, et al. (1996) RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45 (Suppl 3): S77-80.
3. Yan SF, Ramasamy R, Schmidt AM, (2008) Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat Clin Pract Endocrinol Metab 4: 285-293.
4. Lin L, Park S, Lakatta EG, (2009) RAGE signaling in inflammation and arterial aging. Front Biosci 14: 1403-1413.
5. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ, (2010) HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28: 367-388.
6. Hori O, Brett J, Slattery T, Cao R, Zhang J, et al. (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270: 25752-25761.
7. Leclerc E, Fritz G, Vetter SW, Heizmann CW, (2009) Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 1793: 993-1007.
8. Leclerc E, Sturchler E, Vetter SW, Heizmann CW, (2009) Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease. Rev Neurosci 20: 95-110.
9. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, et al. (1997) Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810-17814.
10. Leclerc E, Fritz G, Weibel M, Heizmann CW, Galichet A, (2007) S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem 282: 31317-31331.
11. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, et al. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360.
12. Yeh CH, Sturgis L, Haidacher J, Zhang XN, Sherwood SJ, et al. (2001) Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes 50: 1495-1504.
13. Fages C, Nolo R, Huttunen HJ, Eskelinen E, Rauvala H, (2000) Regulation of cell migration by amphoterin. J Cell Sci 113: 611-620.
14. Gebhardt C, Riehl A, Durchdewald M, Nemeth J, Furstenberger G, et al. (2008) RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 205: 275-285.
15. Sakaguchi M, Sonegawa H, Murata H, Kitazoe M, Futami J, et al. (2008) S100A11, an dual mediator for growth regulation of human keratinocytes. Mol Biol Cell 19: 78-85.
16. Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, et al. (2008) S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 83: 1484-1492.
17. Nukui T, Ehama R, Sakaguchi M, Sonegawa H, Katagiri C, et al. (2008) S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. J Cell Biochem 104: 453-464.
18. Hudson BI, Kalea AZ, Del Mar Arriero M, Harja E, Boulanger E, et al. (2008) Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem 283: 34457-34468.
19. Ishihara K, Tsutsumi K, Kawane S, Nakajima M, Kasaoka T, (2003) The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett 550: 107-113.
20. Lin L, (2006) RAGE on the Toll Road? Cell Mol Immunol 3: 351-358.
21. Ohnishi H, Tochio H, Kato Z, Orii KE, Li A, et al. (2009) Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc Natl Acad Sci U S A 106: 10260-10265.
22. Schmidt AM, Hasu M, Popov D, Zhang JH, Chen J, et al. (1994) Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci U S A 91: 8807-8811.
23. Zhou YJ, Wang JH, Zhang J, (2006) Hepatocyte growth factor protects human endothelial cells against advanced glycation end products-induced apoptosis. Biochem Biophys Res Commun 344: 658-666.
24. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, et al. (1990) Structure and function of lipopolysaccharide binding protein. Science 249: 1429-1431.
25. Youn JH, Oh YJ, Kim ES, Choi JE, Shin JS, (2008) High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J Immunol 180: 5067-5074.
26. Akashi-Takamura S, Miyake K, (2008) TLR accessory molecules. Curr Opin Immunol 20: 420-425.
27. Kawai T, Akira S, (2006) TLR signaling. Cell Death Differ 13: 816-825.
28. van Beijnum JR, Buurman WA, Griffioen AW, (2008) Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11: 91-99.
29. Fedorov YV, Jones NC, Olwin BB, (2002) Atypical protein kinase Cs are the Ras effectors that mediate repression of myogenic satellite cell differentiation. Mol Cell Biol 22: 1140-1149.
30. O'Neill LA, Bowie AG, (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7: 353-364.
31. Gay NJ, Gangloff M, (2007) Structure and function of Toll receptors and their ligands. Annu Rev Biochem 76: 141-165.
32. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, et al. (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13: 1042-1049.
33. Loser K, Vogl T, Voskort M, Lueken A, Kupas V, et al. (2010) The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med 16: 713-717.
34. Jagannathan M, Hasturk H, Liang Y, Shin H, Hetzel JT, et al. (2009) TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol 183: 7461-7470.
35. Drexler SK, Foxwell BM, (2010) The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 42: 506-518.
36. Fukata M, Shang L, Santaolalla R, Sotolongo J, Pastorini C, et al. (2011) Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis 17: 1464-1473.